Bendamustine Hydrochloride Injection for Previously Untreated Chronic Lymphocytic Leukemia
Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether bendamustine is effective in the treatment
of initial treatment of Chronic Lymphocytic Leukemia (CLL).